id,name,drug_type,formula,weight,cas,iupac_name,inchi,smiles,atc_primary,atc_all,external_links,url
DDInter20,Acetylsalicylic acid,small molecule,C9H8O4,180.157,50-78-2,2-(acetyloxy)benzoic acid,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,CC(=O)OC1=CC=CC=C1C(O)=O,B01AC06,"B01AC06 (B01AC06: Aspirin<br>B01AC: Platelet aggregation inhibitors excl. heparin<br>B01A: Antithrombotic agents<br>B01: Antithrombotic agents<br>B: Blood and blood forming organs<br>); C07FX04 (C07FX04: Bisoprolol and acetylsalicylic acid<br>C07FX: Beta blocking agents, other combinations<br>C07F: Beta blocking agents, other combinations<br>C07: Beta blocking agents<br>C: Cardiovascular system<br>); C10BX04 (C10BX04: Simvastatin, acetylsalicylic acid and ramipril<br>C10BX: Lipid modifying agents in combination with other drugs<br>C10B: Lipid modifying agents, combinations<br>C10: Lipid modifying agents<br>C: Cardiovascular system<br>); M01BA03 (M01BA03: Acetylsalicylic acid and corticosteroids<br>M01BA: Antiinflammatory/antirheumatic agents in combination with corticosteroids<br>M01B: Antiinflammatory/antirheumatic agents in combination<br>M01: Antiinflammatory and antirheumatic products<br>M: Musculo-skeletal system<br>); N02BA71 (N02BA71: Acetylsalicylic acid, combinations with psycholeptics<br>N02BA: Salicylic acid and derivatives<br>N02B: Other analgesics and antipyretics<br>N02: Analgesics<br>N: Nervous system<br>); C10BX02 (C10BX02: Pravastatin and acetylsalicylic acid<br>C10BX: Lipid modifying agents in combination with other drugs<br>C10B: Lipid modifying agents, combinations<br>C10: Lipid modifying agents<br>C: Cardiovascular system<br>); B01AC56 (B01AC56: Acetylsalicylic acid, combinations with proton pump inhibitors<br>B01AC: Platelet aggregation inhibitors excl. heparin<br>B01A: Antithrombotic agents<br>B01: Antithrombotic agents<br>B: Blood and blood forming organs<br>); N02AJ07 (N02AJ07: Codeine and acetylsalicylic acid<br>N02AJ: Opioids in combination with non-opioid analgesics<br>N02A: Opioids<br>N02: Analgesics<br>N: Nervous system<br>); N02AJ02 (N02AJ02: Dihydrocodeine and acetylsalicylic acid<br>N02AJ: Opioids in combination with non-opioid analgesics<br>N02A: Opioids<br>N02: Analgesics<br>N: Nervous system<br>); N02BA01 (N02BA01: Aspirin<br>N02BA: Salicylic acid and derivatives<br>N02B: Other analgesics and antipyretics<br>N02: Analgesics<br>N: Nervous system<br>); C10BX05 (C10BX05: Rosuvastatin and acetylsalicylic acid<br>C10BX: Lipid modifying agents in combination with other drugs<br>C10B: Lipid modifying agents, combinations<br>C10: Lipid modifying agents<br>C: Cardiovascular system<br>); N02BA51 (N02BA51: Acetylsalicylic acid, combinations excl. psycholeptics<br>N02BA: Salicylic acid and derivatives<br>N02B: Other analgesics and antipyretics<br>N02: Analgesics<br>N: Nervous system<br>); A01AD05 (A01AD05: Aspirin<br>A01AD: Other agents for local oral treatment<br>A01A: Stomatological preparations<br>A01: Stomatological preparations<br>A: Alimentary tract and metabolism<br>); C10BX01 (C10BX01: Simvastatin and acetylsalicylic acid<br>C10BX: Lipid modifying agents in combination with other drugs<br>C10B: Lipid modifying agents, combinations<br>C10: Lipid modifying agents<br>C: Cardiovascular system<br>); C07FX03 (C07FX03: Metoprolol and acetylsalicylic acid<br>C07FX: Beta blocking agents, other combinations<br>C07F: Beta blocking agents, other combinations<br>C07: Beta blocking agents<br>C: Cardiovascular system<br>); N02AJ18 (N02AJ18: Oxycodone and acetylsalicylic acid<br>N02AJ: Opioids in combination with non-opioid analgesics<br>N02A: Opioids<br>N02: Analgesics<br>N: Nervous system<br>); C10BX12 (C10BX12: Atorvastatin, acetylsalicylic acid and perindopril<br>C10BX: Lipid modifying agents in combination with other drugs<br>C10B: Lipid modifying agents, combinations<br>C10: Lipid modifying agents<br>C: Cardiovascular system<br>); C10BX08 (C10BX08: Atorvastatin and acetylsalicylic acid<br>C10BX: Lipid modifying agents in combination with other drugs<br>C10B: Lipid modifying agents, combinations<br>C10: Lipid modifying agents<br>C: Cardiovascular system<br>); C10BX06 (C10BX06: Atorvastatin, acetylsalicylic acid and ramipril<br>C10BX: Lipid modifying agents in combination with other drugs<br>C10B: Lipid modifying agents, combinations<br>C10: Lipid modifying agents<br>C: Cardiovascular system<br>); C07FX02 (C07FX02: Sotalol and acetylsalicylic acid<br>C07FX: Beta blocking agents, other combinations<br>C07F: Beta blocking agents, other combinations<br>C07: Beta blocking agents<br>C: Cardiovascular system<br>)",DrugBank: https://go.drugbank.com/drugs/DB00945; ChEBI: http://www.ebi.ac.uk/chebi/searchId.do?chebiId=15365; PubChem Substance: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46505803; KEGG Compound: http://www.genome.jp/dbget-bin/www_bget?cpd:C01405; KEGG Drug: http://www.genome.jp/dbget-bin/www_bget?drug:D00109; ChemSpider: http://www.chemspider.com/Chemical-Structure.2157.html; BindingDB: http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22360; PharmGKB: http://www.pharmgkb.org/drug/PA448497; Therapeutic Targets Database: http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000843; Guide to Pharmacology: http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4139; Wikipedia: https://en.wikipedia.org/wiki/Aspirin; ChEMBL: https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL25/; ZINC: https://zinc.docking.org/substances/ZINC000000000053,https://ddinter2.scbdd.com/server/drug-detail/DDInter20/
